• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Laurus Labs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 45955.0
  • ISIN : INE947Q01028
849.35 -25 (-2.86%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    846.00

  • Today’s High

    874.95

  • Open

    874.30

  • Perv Close

    874.35

  • 52W Low

    417.70

  • 52W High

    922.50

Key Indicators

  • P/E(TTM)

    89.84

  • Mar.Cap (₹Cr.)

    45,850.03

  • Div & Yield %

    0.14

  • Book Value(₹)

    84.55

  • Debt-Equity Ratio

    -2.86

  • AGM Date

    01-Aug-2025

  • EPS

    9.44

  • P/E Ratio

    89.84

Financials Ratios

  • Debt-Equity Ratio

    0.56

  • Mar.Cap (₹Cr.)

    45,850.03

  • RONW (%)

    4.13

  • ROCE (%)

    6.31

Score Board

  • Equity (₹ in Cr.)

    107.96

  • BV (₹)

    84.50

  • Sales( ₹ in Cr.)

    5,216.98

  • NP (in Cr.)

    340.02

  • NP Var(%)

    52.0

  • Div%

    60.0

  • CPS (₹)

    12.90

  • EPS (₹)

    6.30

  • Traded Value (₹ in Lakhs)

    45,779.85

  • 52 Week High

    922.50

  • 52 Week Low

    417.70

  • Price BSE

    848.0

  • Price NSE

    849.00

  • Market Capital( in Cr.)

    45,779.85

  • P/C Ratio

    65.50

  • P/E Ratio

    134.60

  • Price Vs.BV

    6.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 5,216.98 4,812.39 5,773.45 4,707.04 4,768.72 2,797.34
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 5,216.98 4,812.39 5,773.45 4,707.04 4,768.72 2,797.34
Other Income 100.47 47.42 15.95 21.55 27.32 5.81
Stock Adjustments 13.55 102.48 -40.82 218.62 296.45 218.09
Total Income 5,331.00 4,962.29 5,748.58 4,947.21 5,092.49 3,021.24
EXPENDITURE :            
Raw Materials 2,476.74 2,507.87 2,671.65 2,427.18 2,471.58 1,620.64
Power and Fuel Cost 289.49 309.67 301.10 188.52 149.69 132.62
Employee Cost 570.78 531.93 477.88 417.57 364.83 299.90
Other Manufacturing Expenses 482.35 491.94 431.99 326.34 298.12 191.38
Selling and Administration Expenses 393.12 293.96 323.95 265.52 260.60 190.04
Miscellaneous Expenses 73.72 29.62 44.30 15.33 10.48 10.62
Employee Benefit Expenses 570.78 531.93 477.88 417.57 364.83 299.90
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 4,286.20 4,164.99 4,250.87 3,640.46 3,555.30 2,445.20
Operating Profit 1,044.80 797.30 1,497.71 1,306.75 1,537.19 576.04
Interest 182.20 150.82 145.70 95.86 65.92 87.71
Gross Profit 862.60 646.48 1,352.01 1,210.89 1,471.27 488.33
Depreciation 358.79 345.01 300.58 235.48 196.64 183.85
Profit Before Tax 503.81 301.47 1,051.43 975.41 1,274.63 304.48
Current Tax 153.84 87.94 270.78 231.42 334.98 53.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -30.42 -10.17 20.27 -6.10 -16.46 -15.57
Reported Net Profit 380.39 223.70 760.38 750.09 956.11 267.05
Extraordinary Items 40.37 -0.57 -0.14 -0.85 -0.63 -0.67
Adjusted Net Profit 340.02 224.27 760.52 750.94 956.74 267.72
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -3.50
P & L Balance brought forward 3,367.61 3,230.09 2,577.18 1,912.95 1,031.88 803.63
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 43.13 86.18 107.47 85.86 75.04 35.30
P & L Balance carried down 3,704.87 3,367.61 3,230.09 2,577.18 1,912.95 1,031.88
Dividend 43.13 86.18 107.47 85.86 75.04 16.04
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 60.00 40.00 100.00 100.00 100.00 25.00
Dividend Per Share(Rs) 1.20 0.80 2.00 2.00 2.00 2.50
Earnings Per Share-Unit Curr 7.05 4.15 14.12 13.96 17.82 24.98
Earnings Per Share(Adj)-Unit Curr 7.05 4.15 14.12 13.96 17.82 5.00
Book Value 84.64 78.06 75.31 63.05 50.54 169.84
Book Value(Adj)-Unit Curr 84.64 78.06 75.31 63.05 50.54 33.97

Shareholding Pattern

  • Promoter Group

    27.59%

  • Public Share Holding

    72.41%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 18,129,978 3.36 18,129,978 14
Partnership Firms-Indian (Promoter & Group) 130,831,740 24.24 130,831,740 2
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 148,961,718 27.59 148,961,718 16
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 1,296 0.00 1,296 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 11 0.00 11 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 138,708,514 25.70 138,708,514 217
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 14,894,596 2.76 14,894,596 12
Mutual Funds / UTI 41,992,237 7.78 41,992,237 33
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 7,559,071 1.40 7,559,071 29
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 203,155,725 37.63 203,155,725 293
2] Non Institution
Bodies Corporate 45,998,271 8.52 45,998,271 1,389
Clearing Members 24,902 0.00 24,902 9
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 10,392,321 1.93 10,392,321 5,946
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,626,460 0.49 2,626,460 3,726
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 48,113,912 8.91 47,992,412 101
Individuals holding nominal share capital up to Rs. 1 lakh 76,696,623 14.21 76,248,840 268,731
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 420,792 0.08 420,792 9
Others 3,434,175 0.64 3,431,050 3
Sub Total 187,707,456 34.77 187,135,048 279,914
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 539,824,899 100.00 539,252,491 280,223

Company Background

Laurus Labs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Laurus Labs Ltd
  • BSE Code : 45955.0
  • ISIN : INE947Q01028

  • Incorporation Year

    2005

  • Registered Office

    Plot No 21 Jawaharlal Nehru
    Pharma City Parawada, Visakhapatnam,
    Andhra Pradesh-531021

  • Telephone

    91-891-3061222

  • FAX

    91-891-3061270

  • Chairman

    Ravindranath Kancherla

  • Managing Director

  • Company Secretary

    G Venkateswar Reddy

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Laurus Labs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Laurus Labs 848.05 5,317.45 5,216.98 89.84 9.14
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10